专利详细信息
专利号 | CN103610651A |
专利标题 | Injection levofloxacin composite freeze-dried powder |
专利权人 | |
发明人 | |
申请号 | CN20131481814 |
申请日 | 2013/10/15 |
公开日 | 2014/3/5 |
优先权号 | |
IPC | A61P03104000; |
专利类型 | |
法律状态查询 | 查看法律状态 |
The invention provides a kind of injection levofloxacin composite freeze-dried powder relate to medicine and medicine manufacture technology field comprise following weight portion material composition: 1.75~2.14 parts of Esomeprazole sodiums 0.87~1.07 part of chitosan nano 94.80~97.38 parts of waters for injection.Advantage of the present invention is: 1) overcome the problem of principal agent poor stability be conducive to Long-term Storage; 2) said composition has synergism in vivo can treat gastric ulcer gastro oesophageal reflux disease (GORD) duodenal ulcer etc. clinically curative effect is rapid through in vitro tests checking the 40mg Esomeprazole sodium of chitosan-containing nanoparticle and not the gastric acid secretion inhibiting effect of the 60mg Esomeprazole sodium of chitosan-containing nanoparticle are equal to; 3) active enhancing is shortened patient's medication cycle has reduced Esomeprazole sodium and has caused the probability that untoward reaction occurs; 4) the alternative mannitol of chitosan nano as the lyophilizing skeleton agent of freeze-dried powder has been eliminated the active function of mannitol to human body.
没有相关的数据
没有相关的数据
暂无附图
注:除CN专利外,本系统默认提供的所有其他中文标题和摘要来自机器翻译。